Samtidig indgift af INTELENCE og lægemidler, der hæmmer CYP3A4, CYP2C9 eller CYP2C19, kan reducere clearance af etravirin og øge plasmakoncentrationen af etravirin.
4 Co-administration of INTELENCE and medicinal products that inhibit CYP3A4, CYP2C9 or CYP2C19 may decrease the clearance of etravirine and may result in increased plasma concentrations of etravirine.